drugset / Trial / NCT01455233
2-Site Safety Study of Besivance Versus Vigamox Prophylactically in Routine Cataract Surgery
Phase 4
Completed
60 enrolled
Ophthalmology Consultants, Ltd.
Bausch & Lomb Incorporated · collabOphthalmology Associates, St Louis · collab
RandomizedParallel-groupSingle-blind
Summary
The purpose of this study is to demonstrate that Besivance is equal to Vigamox in safety and tolerance when used prophylactically in subjects undergoing routine cataract surgery.
Timeline
- Start
- 2010-09
- Primary completion
- 2011-02
- Completion
- 2011-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Besifloxacin | Small molecule | — | Topical |
| Comparator | Moxifloxacin | Small molecule | — | Topical |